Akums Drugs &Pharma, a prominent contract development and manufacturing company in India, launched an ₹1,856-crore IPO with ₹680 crore in fresh issuance. Promoters reduced stakes, and proceeds will tackle debt and working capital. Generating ₹4,178 crore in FY24, Akums serves top pharma brands and stands strong in the expanding market.
Sugar stocks rally continues: Balrampur Chini, Dhampur Sugar, Uttam Sugar Mills rally up to 4%. Two big triggers
Sugar stocks rallied as domestic sugar prices surged sharply over the past month. Government data showed retail prices rising from Rs 48.18/kg on July 20